ReviewObesity and inflammation in children
Introduction
Obesity, a condition resulting from an excess of adipose tissue, has an adverse impact on health. The disability and shortened life span associated with obesity are consequences of comorbid conditions, including insulin resistance, type 2 diabetes, atherosclerotic heart disease, non-alcoholic fatty liver disease, hypertension and hyperlipidaemia. Although the pathogenesis of these conditions is not clearly defined, it is generally accepted that it is related, in part, to the metabolic activity of adipose tissue acting via elevated levels of inflammatory factors, similar to those seen in infection and autoimmune disease.
Inflammation is a primary immune mechanism, sometimes termed ‘innate immunity’. In common acute conditions, e.g. infection and localised trauma, the inflammatory response is the first line of defence. Significant deficiencies in the inflammatory cascade, e.g. the absence of primary inflammatory mediators such as interleukin (IL)-6 or tumour necrosis factor-α (TNF-α), are associated with increased morbidity and mortality.1, 2, 3 However, chronic low-grade levels of inflammation also occur. In obese individuals,4, 5 these are strongly associated with the development of insulin resistance, atherosclerosis and other obesity-related conditions (Table 1).
This review will discuss the relationship between obesity and inflammation in children. It will include a discussion of adipose tissue as a metabolically active organ, the association of inflammation with comorbid conditions of obesity and evidence that modulating inflammation alters obesity and/or its comorbidities.
Section snippets
Classical inflammation and innate immunity
The classic inflammatory response is predominantly a function of the macrophage.6, 7 Inflammation is triggered in macrophages through the Toll-like receptor family. Ten members of this family have been identified, each with specific ligand recognition for various bacterial and fungal proteins. Toll-like receptor 4 (TLR4), which recognises the ligand lipopolysaccharide (LPS), is the best characterised of this family. When LPS is recognised by the TLR4 receptor, it initiates a signalling cascade
Obesity-related inflammation
Obesity is associated with systemic inflammation,5 as evidenced by studies documenting the association of body mass index (BMI) and visceral obesity with circulating levels of cytokines and acute-phase reactants.4, 10, 11 Although the liver participates in the systemic inflammation of obesity, in contrast to the classic inflammatory response, the dominant controlling organ is the adipose tissue.
Early studies showed that adipose tissue of obese mice contained quantitatively more TNF-α mRNA than
Obesity and Inflammation in Children
Obese children of all ages have evidence of a low-grade chronic inflammatory state. In this sense, even the very youngest obese children do not differ from obese adults. In some cases, the degree of inflammation, as measured by circulating acute-phase reactants and cytokines, is correlated with the presence of several of the comorbid conditions of obesity, including insulin resistance, dyslipidaemia, non-alcoholic fatty liver disease (NAFLD), atherosclerosis and hypercoagulation. Direct
Treatment of obesity-related inflammation
The increasing evidence for systemic inflammation in the pathogenesis of comorbid conditions of obesity suggests that therapeutic modification of inflammation might influence their development. Few such studies have been performed in children but information is available from studies in adults.
Summary
Inflammation in obesity is involved in the pathogenesis of a number of serious complications and this effect extends across the age spectrum. The outcome of >30% of children living the majority of their developmental years in a chronic inflammatory state is unknown. Weight loss and lifestyle changes can modify obesity-induced inflammation and some medications can modify obesity-induced inflammation in the absence of weight loss. The study of inflammation in the context of excessive adipose
Practice points
- •
Obesity in childhood is associated with systemic inflammation, correlated with BMI.
- •
Inflammation is associated with many of the complications of obesity and is pathogenic in insulin resistance, atherosclerosis and, possibly, in NAFLD.
- •
Weight loss and/or exercise may reduce systemic inflammation.
Research directions
- •
The mechanism by which increasing adiposity triggers inflammation.
- •
The prevalence of inflammation in very young obese patients and the impact of life-long inflammation on growth and development.
- •
The impact of maternal inflammation in the children of obese mothers.
- •
The role of inflammation in the pathogenesis of other comorbid conditions of obesity, e.g. cancer risk, polycystic ovary syndrome and depression.
Acknowledgements
Dr. Sinaiko is supported by Grants No. HL52851 and M01RR00400 from the National Institutes of Health.
References (79)
Bacterial and protozoal infections in genetically disrupted mice
Curr Opin Immunol
(1994)Is obesity an inflammatory condition?
Nutrition
(2001)- et al.
A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation
J Biol Chem
(1997) Adipose tissue, adipokines, and inflammation
J Allergy Clin Immunol
(2005)- et al.
C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988–1994
J Pediatr
(2001) - et al.
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors
Atherosclerosis
(2000) - et al.
Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents
Metabolism
(2004) - et al.
Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children
J Clin Epidemiol
(2003) - et al.
Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children
Metabolism
(2006) - et al.
Intima media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure
Metabolism
(2006)